Brief: Medibeacon Receives $10 Million In Amended Agreements With Huadong Medicine
16/11/2022 12:01
Nov 16 (Reuters) - Innovate Corp VATE.N :
* MEDIBEACON RECEIVES $10 MILLION IN AMENDED AGREEMENTS WITH
HUADONG MEDICINE TO ACCELERATE DEVELOPMENT OF TRANSDERMAL GFR
MEASUREMENT SYSTEM
Source text for Eikon: ID:nPn92cZQSa
Further company coverage: VATE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innovate
See all newsBrief: Innovate Corp - Enters Tenth Amendment To Credit Agreement With Msd To Extend Maturity To Dec 31, 2026 - SEC Filing
Brief: Innovate Agrees To $650 Million Sale Of Dbm Global To IES Holdings
INNOVATE swings to Q2 profit on higher gross profit and debt extinguishment gains
Brief: INNOVATE Corp. Q2 Revenue USD 421.6 Million
INNOVATE Q1 revenue rises 33%, net loss narrows